These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2242985)

  • 21. [Severe adverse effects of low-dose carbimazole treatment in hyperthyroidism. A retrospective study of 476 patients].
    Eigtved A; Bregengård C; Poulsen S
    Ugeskr Laeger; 1989 Jan; 151(1):23-5. PubMed ID: 2911882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antithyroid drug-induced agranulocytosis. A rare but dreaded condition].
    Lehtihet M; Zedenius J; Helldén A; Axelsson R; Calissendorff J
    Lakartidningen; 2009 Oct 7-13; 106(41):2607-8, 2610-1. PubMed ID: 19927925
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hemosorption in the intensive therapy of agranulocytosis].
    Podgurskaia RA; Sarkisian AP; Al'nikov GP; MIkhaĭlov AP
    Ter Arkh; 1989; 61(11):92-4. PubMed ID: 2633399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbimazole-induced agranulocytosis: does antineutrophil cytoplasmic antibody have a role?
    Yip G; Ekinci E; Lee ST; Jerums G; Grossmann M
    Intern Med J; 2010 Apr; 40(4):300-3. PubMed ID: 20529040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of carbimazole-induced agranulocytosis and sepsis with granulocyte colony stimulating factor.
    Joseph F; Younis N; Bowen-Jones D
    Int J Clin Pract; 2003 Mar; 57(2):145-6. PubMed ID: 12661801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute agranulocytosis during carbimazole treatment].
    Sebaoun J et AL
    Nouv Presse Med; 1977 Sep; 6(31):2778-9. PubMed ID: 593822
    [No Abstract]   [Full Text] [Related]  

  • 27. Pain in the neck: a rare complication of carbimazole therapy.
    Ashman A; Vas P; Patel SK; Melvin A
    Br J Hosp Med (Lond); 2013 Jul; 74(7):409-11. PubMed ID: 24159645
    [No Abstract]   [Full Text] [Related]  

  • 28. Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole.
    Vilchez FJ; Torres I; Garcia-Valero A; López-Tinoco C; de Los Santos A; Aguilar-Diosdado M
    Ann Pharmacother; 2006 Nov; 40(11):2059-63. PubMed ID: 17077174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polyneuropathy during treatment with carbimazole].
    Léger JM; Dancea S; Brunet P; Hauw JJ
    Rev Neurol (Paris); 1984; 140(11):652-6. PubMed ID: 6548829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relapses after thionamide therapy for Graves' disease.
    Holm LE; Alinder I
    Acta Med Scand; 1982; 211(6):489-92. PubMed ID: 6896789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing drugs--only when necessary.
    N Z Med J; 2001 Dec; 114(1145):536. PubMed ID: 11833944
    [No Abstract]   [Full Text] [Related]  

  • 32. Carbimazole-induced agranulocytosis--a report of 2 recent cases.
    Tavintharan S; Rajasoorya C; Chew LS
    Singapore Med J; 1997 Sep; 38(9):386-7. PubMed ID: 9407764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of Graves-Basedow disease].
    Angel M
    Med Clin (Barc); 1988 May; 90(18):748-54. PubMed ID: 2902259
    [No Abstract]   [Full Text] [Related]  

  • 34. [Carbimazole therapy in Basedow's disease: therapy results in individual dosage adjustment].
    Trabucco P; Engler H; Ryff-de Lèche A; Althaus B; Staub JJ
    Schweiz Med Wochenschr; 1989 Dec; 119(52):1894-8. PubMed ID: 2609144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The occurrence of agranulocytosis due to antithyroid drugs in a cohort of patients with Graves disease treated with radioactive iodine 131I during 14 years].
    Límanová Z
    Vnitr Lek; 2014 Oct; 60(10):815-6. PubMed ID: 25612339
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful management of Graves' disease in a patient undergoing regular dialysis therapy.
    McKillop JH; Leung AC; Wilson R
    Arch Intern Med; 1985 Feb; 145(2):337-9. PubMed ID: 3838431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole.
    Clerc J; Izembart M; Dagousset F; Jaïs JP; Heshmati HM; Chevalier A; Léger AF; Barritault L
    J Nucl Med; 1993 Mar; 34(3):387-93. PubMed ID: 8441028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.
    Modebe O
    Afr J Med Med Sci; 1995 Dec; 24(4):347-51. PubMed ID: 8886149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D; Dietlein M; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.